INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of America’s Car-Mart, Inc. - CRMT
NEW YORK, October 29, 2025 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of America’s Car-Mart, Inc. (“America’s Car-Mart” or the “Company”) (NASDAQ: CRMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether America’s Car-Mart and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On September 4, 2025, America’s Car-Mart issued a press release reporting its financial results for the first quarter of fiscal year 2026. Among other items, America’s Car-Mart reported a first-quarter loss of $0.69 per share, compared with a net loss of $0.15 per share for the same period in the prior year. In the press release, America’s Car-Mart President and Chief Executive Officer Doug Campbell said that “[d]uring the quarter wholesale prices rose resulting in each unit of inventory consuming more of our borrowing capacity, which places some limits on how much inventory we can carry.”
On this news, America’s Car-Mart’s stock price fell $8.14 per share, or 18.23%, to close at $36.51 per share on September 4, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
